I agree that this site is using cookies. You can find further informations here.
X
Carmosino, Ida
81  results:
Search for persons X
?
1

Neutrophil to lymphocyte ratio in myelofibrosis patients tr..:

Laganà, Alessandro ; Passucci, Mauro ; Pepe, Sara...
European Journal of Haematology.  112 (2024)  6 - p. 938-943 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Safety and Efficacy of TKIs in very Elderly Patients (≥75 Y..:

Costa, Alessandro ; Abruzzese, Elisabetta ; Latagliata, Roberto...
Journal of Clinical Medicine.  13 (2024)  1 - p. 273 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Ropeginterferon alfa-2b treatment in a young patient with m..:

Ligia, Silvio ; Scalzulli, Emilia ; Carmosino, Ida...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
4

Early death risk score in acute promyelocytic leukemia: A r..:

Costa, Alessandro ; Carmosino, Ida ; Scalzulli, Emilia...
European Journal of Haematology.  112 (2023)  4 - p. 654-657 , 2023
Link: https://doi.org/10.1111/..
 
?
5

Management of Chronic Myeloid Leukemia Patients in Later Li..:

Scalzulli, Emilia ; Carmosino, Ida ; Costa, Alessandro...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  6 - p. 420-425 , 2023
Link: https://doi.org/10.1016/..
 
?
6

One‐month qRT‐PCR BCR::ABL1 transcript threshold to predict..:

Laganà, Alessandro ; Pepe, Sara ; Scalzulli, Emilia...
European Journal of Haematology.  111 (2023)  6 - p. 970-972 , 2023
Link: https://doi.org/10.1111/..
 
?
7

Case Report: Infectious prophylaxis in hematological malign..:

Passucci, Mauro ; Masucci, Chiara ; Paoletti, Francesca...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Case Report: Avelumab and ruxolitinib to manage polycythemi..:

Masucci, Chiara ; Passucci, Mauro ; Scalzulli, Emilia...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

Physicians' Perceptions of Clinical Utility of a Digital He..:

Efficace, Fabio ; Patriarca, Andrea ; Luppi, Mario...
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
10

Myelodysplastic Syndromes with Isolated 20q Deletion: A New..:

Campagna, Alessia ; De Benedittis, Daniela ; Fianchi, Luana...
Journal of Clinical Medicine.  11 (2022)  9 - p. 2596 , 2022
Link: https://doi.org/10.3390/..
 
?
11

Utility of procalcitonin and C-reactive protein as predicto..:

Jabbour, Jean Pierre ; Ciotti, Giulia ; Maestrini, Giacomo...
Supportive Care in Cancer.  , 2022
Link: https://doi.org/10.1007/..
 
?
12

Reduced Klebsiella pneumoniae carbapenemase–producing K. pn..:

Laganà, Alessandro ; Ferri, Gianluca ; Passucci, Mauro...
Infection Control & Hospital Epidemiology.  43 (2022)  12 - p. 1963-1965 , 2022
Link: https://doi.org/10.1017/..
 
?
13

Asciminib as a third line option in chronic myeloid leukemi:

Laganà, Alessandro ; Scalzulli, Emilia ; Carmosino, Ida..
International Journal of Hematology.  117 (2022)  1 - p. 16-23 , 2022
Link: https://doi.org/10.1007/..
 
?
14

CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Step..:

Scalzulli, Emilia ; Carmosino, Ida ; Bisegna, Maria Laura..
Current Hematologic Malignancy Reports.  17 (2022)  6 - p. 198-205 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Deferasirox in the management of iron overload in patients ..:

Elli, Elena Maria ; Di Veroli, Ambra ; Bartoletti, Daniela...
British Journal of Haematology.  197 (2022)  2 - p. 190-200 , 2022
Link: https://doi.org/10.1111/..
 
1-15